Yahoo
Tokyo - Delayed Quote JPY

COSMOS Pharmaceutical Corporation (3349.T)

6,002.00 -30.00 (-0.50%)
At close: November 2 at 3:30:00 PM GMT+9
Dividend
3349.T announced a cash dividend of JPY 42.00 with an ex-date of Nov. 27, 2026
Chart Range Bar
Loading chart for 3349.T
  • Previous Close 6,032.00
  • Open 6,020.00
  • Bid 5,981.00 x --
  • Ask 6,008.00 x --
  • Day's Range 5,980.00 - 6,068.00
  • 52 Week Range 5,615.00 - 8,121.00
  • Volume 474,300
  • Avg. Volume 446,531
  • Market Cap (intraday) 475.702B
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 14.81
  • EPS (TTM) 405.34
  • Earnings Date (est.) Jan 13, 2027
  • Forward Dividend & Yield 84.00 (1.40%)
  • Ex-Dividend Date Nov 27, 2026
  • 1y Target Est 7,460.00

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, over-the-counter drugs, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and cosmetics, men's cosmetics, hair care, and bath additives products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products. In addition, the company engages in the maintenance and management of buildings and commercial facilities, traffic control, and security contracting activities. It sells its products through retail stores and online. COSMOS Pharmaceutical Corporation was incorporated in 1983 and is headquartered in Fukuoka City, Japan.

www.cosmospc.co.jp

5,984

Full Time Employees

May 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

3349.T
23.86%
Nikkei 225 (^N225)
25.31%

1-Year Return

3349.T
11.91%
Nikkei 225 (^N225)
20.36%

3-Year Return

3349.T
21.73%
Nikkei 225 (^N225)
97.44%

5-Year Return

3349.T
28.43%
Nikkei 225 (^N225)
113.69%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 286.65B
Earnings 8.25B
Profit Margin 2.88%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
100B
200B
2.6%
2.8%
3.0%
3.2%

Analyst Insights

View More

Analyst Price Targets

6,700.00
7,460.00 Average
6,002.00 Current
9,600.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.88%

  • Return on Assets (ttm)

    4.74%

  • Return on Equity (ttm)

    11.66%

  • Revenue (ttm)

    1.11T

  • Net Income Avi to Common (ttm)

    32.13B

  • Diluted EPS (ttm)

    405.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    39.37B

  • Total Debt/Equity (mrq)

    23.74%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: